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Abstract
Background: The C825T polymorphism (rs5443) of the Guanine Nucleotide-Binding protein subunit β3 (GNB3)
gene has been associated with obesity, essential hypertension, atherosclerosis, coronary diseases, and
cerebrovascular events, but with some sex-specific effects. Its association with inflammatory mediators such as cell
adhesion molecules has not been studied, although they are heavily involved in cardiovascular diseases’ (CVDs)
processes. The aim of our study was then to investigate a possible sex-specific effect of the GNB3 C825T
polymorphism on serum soluble cell adhesion molecules such as E, P and L-selectins (sE, sP and sL-selectins).
Results: Participants were from the STANISLAS Family Study and were free of chronic disease as CVDs or cancer.
We included in total 771 subjects aged 6 to 58 years (391 males (50.71%) and 380 females (49.29%)). No significant
association of rs5443 was observed in the whole population with serum sE, sP and sL-selectins after adjusting for
age, sex, body mass index, systolic blood pressure, anti-inflammatory drugs and hormonal drugs consumption. A
significant interaction of rs5443 was observed with sex for sE-selectin (p < 0.001), but not for sP and sL-selectins.
After adjusting for covariables, the T allele was significantly associated with an additive increase effect on serum sE-
selectin levels in males (β = 5.03 ± 2.18; p = 0.020), while a significant additive decrease effect was observed in
females (β =−4.46 ± 2.06; p = 0.030). These associations stayed significant after correction for multiple tests (p = 0.045
in males and in females). The additive phenotypic variance was 21.54% in males versus 1.91% in females.
Conclusions: In our Caucasian population, the GNB3 C825T polymorphism showed a significant sex-specific effect
on serum sE-selectin levels, with a disadvantage for males, as increased sE-selectin levels has been associated with
CVDs outcomes. The T allele has been previously associated with the same CVDs as increased sE-selectin, but more
often in males. The link we observed between this polymorphism and E-selectin is then consistent with previous
findings, and helps to better understand the deleterious effect of the GNB3 825 T allele on CVDs outcomes in
males. We revealed in this study an important pathway through which the GNB3 gene induces CVDs’ outcomes.
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Background
The Guanine Nucleotide-Binding protein subunit β3
(GNB3) gene is present on chromosome 12 at the location
12p13 and presents a polymorphism called rs5443, result-
ing from a cytosine (C) to a thymine (T) substitution at
position 825 (C825T) located in exon 10 of the gene [1].
This polymorphism is involved in cardiovascular patho-
physiological processes and cardiovascular diseases (CVDs).
Indeed, it has been associated with obesity [2], higher blood
pressure [3], hypertension [1, 4, 5], carotid atherosclerosis
[6], incident cerebrovascular events [7] and coronary dis-
eases [8], even though these effects have also been contro-
verted in the literature [9, 10].
Some of these studies showed a sex-specific effect of
this single nucleotide polymorphism (SNP). Brand et al.
observed a higher blood pressure in T homozygotes
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males than in C allele male carriers, while no significant
difference was observed in females [3]. Hengstenberg et
al. also observed a significantly higher prevalence of ar-
terial hypertension in TT genotype subjects as compared
to the other genotypes, but this association was predom-
inantly found in men [4]. Frey et al. observed that the
TT genotype was a significant risk factor for fatal and
non-fatal myocardial infarction, independently of other
established cardiovascular risk factors at a population
level, but only in males, while in females no significant
association was observed [8]. All these elements encour-
age further investigations of a sex-specific effect of this
polymorphism.
Furthermore, the association of the GNB3 825 T allele
with lipids, body mass index (BMI) [11], and blood pres-
sure [1, 3–5] have been studied but not with molecules
involved in inflammatory pathways such as cell adhesion
molecules (CAM), while their importance in cardiovas-
cular processes is well known [11, 12].
In this perspective, the aim of our present study was to
investigate a possible sex-specific effect of the GNB3
C825T polymorphism on the serum soluble cell adhesion
molecules E, P and L-selectins (sE, sP and sL-selectins).
Methods
Study participants
Participants are from the STANISLAS (Suivi Temporaire
annuel Non Invasif de la Santé des Lorrains Assurés
sociaux) Family Study (SFS), a 15-year longitudinal
monocentric family survey. Individuals were invited to
three quinquennial medical check-ups that were held in
1994–1995, 1998–2000, and 2000–2003 [13, 14]. The SFS
includes Caucasian volunteers, frequenting the Centre for
Preventive Medicine of Vandoeuvre-lès-Nancy (East of
France). All the subjects recruited were free of chronic
diseases as CVDs or Cancer. Data on sE, sP and sL-
selectins have been collected for subjects present during
the second quinquennial medical check-up which oc-
curred in 1998–2000. Among the 2,532 subjects (754 fam-
ilies) present at this second recruitment, we included those
who were genotyped for the SNP rs5443, and for which
data on the following factors were available: age, sex, BMI,
systolic blood pressure (SBP), and anti-inflammatory drugs
consumption (nonsteroidal drugs and corticosteroids). In
females, we added a supplementary criterion: the availabil-
ity of data about hormonal drugs consumption including
oral contraceptives and hormonal replacement therapy
containing oestrogen or progesterone).
Blood samples and data collection
Serum concentrations of sE, sP and sL-selectins were
measured using commercially available enzyme-linked
immunosorbent essay according to the manufacturer’s
specifications (ELISA kits, R&D Systems, Abingdon,
Oxon, UK). The intra- and inter-assay coefficients of
variation were as follows: sE-selectin, 9.4 and 14.9%
(sensitivity: 0.027 ng/mL, assay range: 0.1–8 ng/mL);
sP-selectin, 5.8 and 7.0% (sensitivity: 0.5 ng/mL, assay
range: 0.8–46 ng/mL); sL-selectin, 8.9 and 11.7% (sensitiv-
ity: 0.3 ng/mL, assay range: 1.0–58 ng/mL), respectively.
Frozen aliquots of serum were stored in the Biological
Resources Centre (BRC) “Interactions Gène-Environne-
ment en Physiopathologie CardioVasculaire” (IGE-PCV).
Information about drug consumption and personal
medical history was collected using relevant question-
naires and procedures under the supervision of
trained nurses.
Weight and height were measured while the partici-
pants were standing in light clothing without shoes and
BMI was calculated as weight in kilograms divided by
height in meters squared.
Blood pressure was measured under constant temperature
(19 °C-21 °C) and standardized conditions (supine position)
using a manual sphygmomanometer. The recorded values
were the means of 3 readings on 20 min intervals.
Genotyping
Genomic DNA was extracted from venous blood sam-
ples by the salting-out method [15]. Genotyping of the
SNP rs5443 was part of a multilocus assay performed
with an immobilized probe approach designed by Roche
Molecular Systems, Pleasanton, California, USA [16].
Genotyping was validated by classical Polymerase Chain
Reaction methodology [17] in 50 individuals.
Statistical analysis
The Hardy-Weinberg Equilibrium (HWE) of our study
population was verified by a Chi square test. For statis-
tical analyses, we used parametric method. The normal-
ity of the distribution was tested by Kolmogorov-
Smirnov test. We controlled variances homogeneity of
the compared groups, by the test of Levene.
The three phenotypes (sE, sP and sL-selectins) were
introduced in a genetic additive model as quantitative
variables, in an observational transversal and analytical
design. The SNP effect was tested by a linear regression
model, using an ANalysis Of VAriance (ANOVA). Co-
variates introduced in the model for adjustment are age,
sex, BMI, SBP, and anti-inflammatory drug consumption.
Age, BMI and SBP were considered in the model in their
quantitative form. In the model testing the SNP effect in
females, we added “hormonal drug consumption” as a
supplementary qualitative covariate. Familial correlations
in our study population were accounted for by using a
linear mixed effects model that uses a relationship coef-
ficient matrix as within pedigree correlation structure.
We performed analyses with the R package GWAF
(Genome-Wide Association/Interaction Analysis and
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Rare Variant analysis with Family Data) [18]. The type I
error, alpha was fixed at 5%. The power of our study has
been calculated a posteriori with the Quanto software
(http://biostats.usc.edu/Quanto.html).
Firstly we tested the association of the SNP rs5443
with phenotypes in the whole population, and secondly
we tested the SNP interaction with sex. If a significant
interaction of the SNP with sex was observed for a
phenotype, we then tested a new association of the SNP
with this phenotype separately in males and in females.
A False Discovery Rate (FDR) correction was done in
this case, for the SNP associations’ p-values.
Results and discussion
We included in total 771 subjects aged 6 to 58 years in
our study, involving 391 males (50.7%) and 380 females
(49.3%) (Fig. 1). Table 1 shows the characteristics of the
study population, and Table 2, the genotypes distribution
of the SNP rs5443 in the studied population. The total
population showed no significant deviation from the
HWE (p = 0.409). Table 3 shows the means and confi-
dence intervals at 95% of quantitative variables
introduced in the linear regression model testing the
SNP effect on selectins.
In the whole population
The additive model showed no significant result for sP, sL,
and sE-selectins (respective p-values = 0.876, 0.158 and
0.770) after adjusting for covariables (sex, age, SBP, BMI,
hormonal drugs, or anti-inflammatory drug consumption).
Interaction of the SNP with sex
After adjusting for covariables, the interaction of rs5443
with sex was significant with sE-selectin (p < 0.001) while
Fig. 1 Flow chart of the selected population. 1. Serum Soluble E, P
and L-selectins. 2. Age, sex, body mass index, systolic blood pressure,
anti-inflammatory drugs, and hormonal drugs consumption (oral
contraceptives and hormonal replacement therapy containing
oestrogen or progesterone)
Table 1 Characteristics of the study population








< 18.5 11.5 13.7 12.6
18.5–25 61.6 66.3 63.9
25–30 22.5 15.5 19.1
> =30 4.3 17 4.4
Age (years)
< 15 15.9 17.4 16.6
15–24 37.6 34.7 36.2
25–34 2.0 1.3 1.7
35–44 21.5 32.1 26.7
45–54 22.5 14.2 18.4
55–64 0.5 0.3 0.4
SBP(mmHg)
< 120 41.7 62.6 52.0
120–139 50.9 31.6 41.4
140–159 7.4 5.0 6.2
> =160 0.0 0.8 0.4
Anti-inflammatory drug consumption
Yes 3.8 5.0 4.4
No 96.2 95.0 95.6
Hormonal drug consumption
Yes 0 31.6 15.6
No 100 68.4 84.4
BMI Body Mass Index, SBP Systolic Blood Pressure
Table 2 Genotype distribution and allele frequencies in the
studied population
Genotypes Males Females Total Population
n % n % n %
CC 176 45.0 158 41.6 334 43.3
CT 171 43.7 168 44.2 339 44.0
TT 44 11.3 54 14.2 98 12.7
Total 391 100.0 380 100.0 771 100.0
Minor Allele Frequencies in males, Females and total population were
respectively 33.5, 37.0, 35.7%
p-value of Hardy-Weinberg Equilibrium test was 0.4
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the results with sP and sL-selectins were not significant
(p = 0.079 and p = 0.607 respectively). Indeed, in the
multivariate analysis, the T allele was significantly associ-
ated with an increased additive effect on serum sE-
selectin levels in males (p = 0.020), while in females we
observed a significantly decreased additive effect (p =
0.030). After correction by the FDR method, p-values
remained statistically significant in males (p = 0.045) and
females (p = 0.045). The effects of the T allele on sE-
selectin in males, females and the whole population are
illustrated in Fig. 2.
Additive genetic variances
The proportion of sE-selectin variance explained by the
genetic additive effect in males was 21.54% versus only
1.91% in females.
Association of the C825T polymorphism with E-selectin
This study revealed a significant additive effect of the
GNB3 C825T polymorphism on serum sE-selectin levels,
in males and females populations.
E-selectin also called Endothelial-Leucocyte Adhesion
Molecule 1 (ELAM 1) is a cell surface glycoprotein
expressed by endothelial cells (ECs) and is involved in
leukocyte adhesion [19]. Its levels are increased during
endothelial dysfunction and vascular remodelling [20, 21].
Increased levels of sE-selectin have been associated with
atherosclerosis [22, 23], essential hypertension [24, 25],
cerebrovascular diseases [26] and coronary artery diseases
[27, 28]. The GNB3 C825T polymorphism has been asso-
ciated with these same CVDs, as aforementioned [1–8]. A
link between the GNB3 C825T polymorphism and E-
selectin is then consistent with previous findings, even if
Table 3 Means and confidence intervals of quantitative variables introduced in the linear regression model, studying the SNP rs5443
effect on serum soluble selectins in the STANISLAS population
Means CI (95%)
Variables Total population Males Females
sE-selectin (mg/l) 56.0 [54.0;58.0] 60.0 [57.1; 62.9] 51.8 [49.0; 54.5]
sP-selectin (mg/l) 132.5 [129.7; 135.3] 140.5 [136.4; 144.5] 124.4 [120.8; 128.0]
sL-Selectin (g/l) 1227.7 [1191.0; 1264.3] 1221.4 [1165.5; 1275.5] 1234.1 [1185.4; 1282.04]
Age (years) 29.4 [28.4; 30.4] 29.5 [28.1; 31.0] 29.3 [27.9; 30.7]
BMI (kg/m2) 22.5 [22.2; 22.8] 22.8 [22.4; 23.2] 22.2 [21.8; 22.6]
SBP (mmHg) 120.0 [119.1; 120.9] 122.4 [121.2; 123.6] 117.5 [116.3; 118.8]
CI(95%): Confidence Interval at 95%
Dependent variables: sE, sP, and sL-selectins (serum soluble E, P and L-selectins), Covariables: BMI, SBP, Age
BMI body mass index, SBP systolic blood pressure
Fig. 2 Effects of the GNB3 825 T allele on serum soluble E-selectin levels in the STANISLAS population. 1. The additive genetic effects of the GNB3 825 T
allele on serum soluble E-selectins levels (mg/l), in the total population (N= 771), and separetly in males (n= 391) and females (n= 380). 2. Standard error
of the effects. *P-value ≤ 0.05 (Significance level) after false discovery rate correction: The GNB3 825 T allele significantly increased serum soluble E-selectin
levels in males and significantly decreased these levels in females, while in the total population (males + females), no significant effect was observed
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current knowledge does not show a direct involvement of
the GNB3 gene in the production of E-selectin molecule.
This molecule is rather encoded by the SELE (Selectin E)
gene [29]. However, the GNB3 gene may be involved in a
mechanism regulating levels of E-selectin.
The GNB3 gene encodes a beta subunit of the hetero-
trimeric guanine nucleotide-binding proteins also called
G proteins which transmit signals from the cell surface
to intracellular signal cascades [30]. It is established that
G proteins play important roles in regulating the cardio-
vascular system [25]. Gudi et al. have studied the in-
volvement of G proteins in mechanochemical signal
transduction and reported that within the circulation,
endothelial alignment, atherosclerotic lesion formation,
vascular remodelling, and vasoactive molecule release
are all mediated in part by hemodynamic forces, with G-
protein activation [31]. Authors also concluded that G
proteins are closely associated with the flow-stimulated
mechanochemical transducer within endothelial cells. It
has been demonstrated that fluid mechanical forces
directly influence endothelial cell structure and function
[32]. In this perspective, Chappel et al. showed that pro-
longed oscillatory fluid shear stress induces expression
of endothelial cell leukocyte adhesion molecules, including
E-selectin [33]. We suggest that the link between the
GNB3 C825T polymorphism and E-selectin found in this
study is possible through G proteins’ effect within endo-
thelial cells, by a mechanotransduction process. Other-
wise, the GNB3 C825T polymorphism is associated with
increased transmembrane signal transduction [1]. In this
SNP’ carriers, G proteins may therefore have enhanced
activity within endothelial cells, and consequently gener-
ates high levels of E-selectin.
A likely association of the GNB3 C825T polymorphism
with P-selectin
P-selectin is expressed in activated endothelial cells as well
as E-selectin, while L-selectin is expressed on leukocytes
[34]. Knowing the effect of G proteins within endothelial
cells, we can assume that the GNB3 C825T polymorphism
association would also be positive for P-selectin, but not
with L-selectin. Our results seem to follow this trend.
Indeed, we found that the sex-specific effect of the SNP
was likely with P-selectin (p-value = 0.08), but unlikely
with L-selectin (p-value = 0.61). We think that in a larger
population, the sex-specific effect will also be positive for
P-selectin at a significance level of 5%. We specify that
confounding factors as antiplatelet medications or antico-
agulants can hide this association. In our study popula-
tion, none of the subjects reported taking these drugs.
Interaction of the SNP rs5443 with sex, on sE-selectin
In our study, increased levels of sE-selectin have been
observed in males but not in females. We observed that
the strength of the SNP effect on sE-selectin was
approximately similar in males and in females (varying
between 2.85–7.21 for males and 2.40–6.52 for females)
while the direction of the effect was opposite in these
two sex groups. We can then conclude on a significant
qualitative interaction of this SNP with sex on sE-
selectin levels (p < 0.001). This sex-specificity explains
why we were not able to detect this SNP’s effect in the
whole population, as the addition of the opposite effects
resulted in an almost null global effect.
These results demonstrate the importance of looking
for a sex-specific effect of one or more variants that can
constitute a study in itself. Indeed, sex-specific studies
can reveal interesting associations that would be hidden
in classical genetic association studies.
In our study, we also observed that the additive vari-
ance explained by the SNP rs5443 was more than 20%
in males while this proportion was ten times less in fe-
males. Genetic factors seem to have a more pronounced
effect on E-selectin phenotype in males, while in fe-
males, other elements as constitutional or environmental
factors and their interactions might be more implicated.
We could explain this sex-specificity by (inter alia)
hormonal interactions. Indeed, Caulin-Glaser et al., in
their study on subjects with coronary artery disease,
observed a statistically significant increase in sE-selectin
levels in men and postmenopausal women not receiving
oestrogen replacement therapy (ERT) compared with
women receiving ERT [35]. Others studies revealed that, a
decrease in the number of inflammatory cells is observed,
in follicular phase, in cyclic women, when oestrogen level
is high, compared to an increase in males and post-
menopausal females [36, 37]. Then, the SNP interaction
with sex in our study could be due to hormonal influence
in females. Indeed, our study focused on a Caucasian
population from an industrilized country and it has been
reported that the age at menopause among women from
this population is around midlife. [38]. The proportion of
women over 50 years in our study is only 0.04% (17
women). Our results in females may therefore be influ-
enced by this selection bias about hormonal status.
In males, a case-control study of Wang et al. showed a
significant interaction between the SELE gene and sex
on essential hypertension [39]. The SELE gene was not
associated with essential hypertension in females. Know-
ing the effect of the GNB3 825 T allele on essential
hypertension often found in males, the sex-specific effect
of this polymorphism on E-selectin observed in our
study is consistent with this finding.
Our results help to better understand in males, the dele-
terious effect of the GNB3 gene on CVDs, as hypertension.
We suggest that the GNB3 C825T polymorphism may
improve significantly endothelial cells activities in inflam-
matory pathways, by an enhanced mechanotransduction
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signalling in males carriers of this variant, and conse-
quently induces susceptibility to CVDs.
Limitations and perpectives
In our study, the significance regarding the effects of the
825 T allele on sE-selectin in males and females is mar-
ginal after FDR correction (p = 0.045). We acknowledge
that a replication in a larger study population would
ameliorate the data dispersion and significantly improve
the precision of the estimates.
It would be interesting that replication studies test
hormonal interaction with the GNB3 C825T polymorph-
ism on E-selectin. We were not able to test this inter-
action in our study, as the proportion of women over
50 years was low.
Although we have demonstrated in this study an effect
of the GNB3 C825T polymorphism on sE-selectin, the
precise mechanism of this gene on E-selectin molecule
need to be clarified by further investigations.
The results of our study support an involvement of the
SNP rs5443 in CVDs, particularly in men. A question aris-
ing from this observation is whether special monitoring in
males carrying this variant is needed, especially when the
mean age of cardiovascular risk is reached. Controversial
results of some studies on this issue did not allow authors
to decide clearly about it. Otherwise, the impact of this
variant on CVDs’ outcomes was investigated but it would
be also interesting to focus on its impact as cardiovascular
prognostic factor to determine whether the evolution of
CVD in carriers of this polymorphism is adverse or not.
This could lead to consider therapeutic targets fitting this
profile of patients. In this context, knowledge about the
mechanism of this variant in the cardiovascular patho-
physiological process would be of great use.
Conclusions
In this present study, we were able to highlight, in
Caucasians, a sex-specific association between the GNB3
825 T allele and sE-selectin, with however a disadvantage
for males concerning the known impact of increased E-
selectin on CVDs’ outcomes. This association might be
hidden in classical studies, because of the opposite effect
observed in males as compared to females. Our findings
revealed an important pathway through which the GNB3
gene induces CVDs’ outcomes and help to better under-
stand the deleterious effect of the 825 T allele on CVDs
outcomes in males.
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